Matches in Nanopublications for { <http://www.w3.org/1999/02/22-rdf-syntax-ns#SUBJECT> ?p ?o ?g. }
- SUBJECT label "use of intravenous dexamethasone plus standard care compared with standard care alone" provenance.
- SUBJECT label "use of intravenous dexamethasone plus standard care compared with standard care alone" provenance.
- SUBJECT label "use of intravenous dexamethasone plus standard care compared with standard care alone" provenance.
- SUBJECT label "use of intravenous dexamethasone plus standard care compared with standard care alone" provenance.
- SUBJECT label "use of intravenous dexamethasone plus standard care compared with standard care alone" provenance.
- SUBJECT label "use of intravenous dexamethasone plus standard care compared with standard care alone" provenance.
- SUBJECT label "use of intravenous dexamethasone plus standard care compared with standard care alone" provenance.
- SUBJECT label "use of intravenous dexamethasone plus standard care compared with standard care alone" provenance.
- SUBJECT label "use of intravenous dexamethasone plus standard care compared with standard care alone" provenance.
- SUBJECT label "use of intravenous dexamethasone plus standard care compared with standard care alone" provenance.
- SUBJECT label "use of intravenous dexamethasone plus standard care compared with standard care alone" provenance.
- SUBJECT label "use of intravenous dexamethasone plus standard care compared with standard care alone" provenance.
- SUBJECT label "use of intravenous dexamethasone plus standard care compared with standard care alone" provenance.
- SUBJECT label "use of intravenous dexamethasone plus standard care compared with standard care alone" provenance.
- SUBJECT label "use of intravenous dexamethasone plus standard care compared with standard care alone" provenance.
- SUBJECT label "use of intravenous dexamethasone plus standard care compared with standard care alone" provenance.
- SUBJECT label "use of intravenous dexamethasone plus standard care compared with standard care alone" provenance.
- SUBJECT label "use of intravenous dexamethasone plus standard care compared with standard care alone" provenance.
- SUBJECT label "use of intravenous dexamethasone plus standard care compared with standard care alone" provenance.
- SUBJECT label "use of intravenous dexamethasone plus standard care compared with standard care alone" provenance.
- SUBJECT label "tocilizumab" assertion.
- SUBJECT label "tocilizumab" assertion.
- SUBJECT label "tocilizumab" assertion.
- SUBJECT label "tocilizumab" assertion.
- SUBJECT label "tocilizumab" assertion.
- SUBJECT label "tocilizumab" assertion.
- SUBJECT label "tocilizumab" assertion.
- SUBJECT label "tocilizumab" assertion.
- SUBJECT label "disease" provenance.
- SUBJECT label "disease" provenance.
- SUBJECT label "disease" provenance.
- SUBJECT label "disease" provenance.
- SUBJECT label "64" assertion.
- SUBJECT label "dexamethasone antiemetic prophylaxis" provenance.
- SUBJECT label "dexamethasone antiemetic prophylaxis" provenance.
- SUBJECT label "dexamethasone antiemetic prophylaxis" provenance.
- SUBJECT label "dexamethasone antiemetic prophylaxis" provenance.
- SUBJECT label "dexamethasone antiemetic prophylaxis" provenance.
- SUBJECT label "dexamethasone antiemetic prophylaxis" provenance.
- SUBJECT label "dexamethasone antiemetic prophylaxis" provenance.
- SUBJECT label "dexamethasone antiemetic prophylaxis" provenance.
- SUBJECT label "dexamethasone antiemetic prophylaxis" provenance.
- SUBJECT label "dexamethasone antiemetic prophylaxis" provenance.
- SUBJECT label "dexamethasone antiemetic prophylaxis" provenance.
- SUBJECT label "dexamethasone antiemetic prophylaxis" provenance.
- SUBJECT label "dexamethasone )" provenance.
- SUBJECT label "dexamethasone )" provenance.
- SUBJECT label "dexamethasone )" provenance.
- SUBJECT label "dexamethasone )" provenance.
- SUBJECT label "dexamethasone )" provenance.
- SUBJECT label "dexamethasone )" provenance.
- SUBJECT label "dexamethasone )" provenance.
- SUBJECT label "dexamethasone )" provenance.
- SUBJECT label "dexamethasone )" provenance.
- SUBJECT label "dexamethasone )" provenance.
- SUBJECT label "dexamethasone )" provenance.
- SUBJECT label "dexamethasone )" provenance.
- SUBJECT label "dexamethasone )" provenance.
- SUBJECT label "The PK model of dopamine D(2)-like receptor ( D2DR ) antagonist sulpiride ( SUL ) as well as that of dexamethasone ( DEX ) with a time-dependent clearance" provenance.
- SUBJECT label "The PK model of dopamine D(2)-like receptor ( D2DR ) antagonist sulpiride ( SUL ) as well as that of dexamethasone ( DEX ) with a time-dependent clearance" provenance.
- SUBJECT label "The PK model of dopamine D(2)-like receptor ( D2DR ) antagonist sulpiride ( SUL ) as well as that of dexamethasone ( DEX ) with a time-dependent clearance" provenance.
- SUBJECT label "The PK model of dopamine D(2)-like receptor ( D2DR ) antagonist sulpiride ( SUL ) as well as that of dexamethasone ( DEX ) with a time-dependent clearance" provenance.
- SUBJECT label "The PK model of dopamine D(2)-like receptor ( D2DR ) antagonist sulpiride ( SUL ) as well as that of dexamethasone ( DEX ) with a time-dependent clearance" provenance.
- SUBJECT label "The PK model of dopamine D(2)-like receptor ( D2DR ) antagonist sulpiride ( SUL ) as well as that of dexamethasone ( DEX ) with a time-dependent clearance" provenance.
- SUBJECT label "The PK model of dopamine D(2)-like receptor ( D2DR ) antagonist sulpiride ( SUL ) as well as that of dexamethasone ( DEX ) with a time-dependent clearance" provenance.
- SUBJECT label "The PK model of dopamine D(2)-like receptor ( D2DR ) antagonist sulpiride ( SUL ) as well as that of dexamethasone ( DEX ) with a time-dependent clearance" provenance.
- SUBJECT label "The PK model of dopamine D(2)-like receptor ( D2DR ) antagonist sulpiride ( SUL ) as well as that of dexamethasone ( DEX ) with a time-dependent clearance" provenance.
- SUBJECT label "The PK model of dopamine D(2)-like receptor ( D2DR ) antagonist sulpiride ( SUL ) as well as that of dexamethasone ( DEX ) with a time-dependent clearance" provenance.
- SUBJECT label "The PK model of dopamine D(2)-like receptor ( D2DR ) antagonist sulpiride ( SUL ) as well as that of dexamethasone ( DEX ) with a time-dependent clearance" provenance.
- SUBJECT label "The PK model of dopamine D(2)-like receptor ( D2DR ) antagonist sulpiride ( SUL ) as well as that of dexamethasone ( DEX ) with a time-dependent clearance" provenance.
- SUBJECT label "The PK model of dopamine D(2)-like receptor ( D2DR ) antagonist sulpiride ( SUL ) as well as that of dexamethasone ( DEX ) with a time-dependent clearance" provenance.
- SUBJECT label "The PK model of dopamine D(2)-like receptor ( D2DR ) antagonist sulpiride ( SUL ) as well as that of dexamethasone ( DEX ) with a time-dependent clearance" provenance.
- SUBJECT label "The PK model of dopamine D(2)-like receptor ( D2DR ) antagonist sulpiride ( SUL ) as well as that of dexamethasone ( DEX ) with a time-dependent clearance" provenance.
- SUBJECT label "The PK model of dopamine D(2)-like receptor ( D2DR ) antagonist sulpiride ( SUL ) as well as that of dexamethasone ( DEX ) with a time-dependent clearance" provenance.
- SUBJECT label "The PK model of dopamine D(2)-like receptor ( D2DR ) antagonist sulpiride ( SUL ) as well as that of dexamethasone ( DEX ) with a time-dependent clearance" provenance.
- SUBJECT label "The PK model of dopamine D(2)-like receptor ( D2DR ) antagonist sulpiride ( SUL ) as well as that of dexamethasone ( DEX ) with a time-dependent clearance" provenance.
- SUBJECT label "The PK model of dopamine D(2)-like receptor ( D2DR ) antagonist sulpiride ( SUL ) as well as that of dexamethasone ( DEX ) with a time-dependent clearance" provenance.
- SUBJECT label "The PK model of dopamine D(2)-like receptor ( D2DR ) antagonist sulpiride ( SUL ) as well as that of dexamethasone ( DEX ) with a time-dependent clearance" provenance.
- SUBJECT label "The PK model of dopamine D(2)-like receptor ( D2DR ) antagonist sulpiride ( SUL ) as well as that of dexamethasone ( DEX ) with a time-dependent clearance" provenance.
- SUBJECT label "The PK model of dopamine D(2)-like receptor ( D2DR ) antagonist sulpiride ( SUL ) as well as that of dexamethasone ( DEX ) with a time-dependent clearance" provenance.
- SUBJECT label "The PK model of dopamine D(2)-like receptor ( D2DR ) antagonist sulpiride ( SUL ) as well as that of dexamethasone ( DEX ) with a time-dependent clearance" provenance.
- SUBJECT label "The PK model of dopamine D(2)-like receptor ( D2DR ) antagonist sulpiride ( SUL ) as well as that of dexamethasone ( DEX ) with a time-dependent clearance" provenance.
- SUBJECT label "The PK model of dopamine D(2)-like receptor ( D2DR ) antagonist sulpiride ( SUL ) as well as that of dexamethasone ( DEX ) with a time-dependent clearance" provenance.
- SUBJECT label "The PK model of dopamine D(2)-like receptor ( D2DR ) antagonist sulpiride ( SUL ) as well as that of dexamethasone ( DEX ) with a time-dependent clearance" provenance.
- SUBJECT label "The PK model of dopamine D(2)-like receptor ( D2DR ) antagonist sulpiride ( SUL ) as well as that of dexamethasone ( DEX ) with a time-dependent clearance" provenance.
- SUBJECT label "The PK model of dopamine D(2)-like receptor ( D2DR ) antagonist sulpiride ( SUL ) as well as that of dexamethasone ( DEX ) with a time-dependent clearance" provenance.
- SUBJECT label "The PK model of dopamine D(2)-like receptor ( D2DR ) antagonist sulpiride ( SUL ) as well as that of dexamethasone ( DEX ) with a time-dependent clearance" provenance.
- SUBJECT label "The PK model of dopamine D(2)-like receptor ( D2DR ) antagonist sulpiride ( SUL ) as well as that of dexamethasone ( DEX ) with a time-dependent clearance" provenance.
- SUBJECT label "The PK model of dopamine D(2)-like receptor ( D2DR ) antagonist sulpiride ( SUL ) as well as that of dexamethasone ( DEX ) with a time-dependent clearance" provenance.
- SUBJECT label "The PK model of dopamine D(2)-like receptor ( D2DR ) antagonist sulpiride ( SUL ) as well as that of dexamethasone ( DEX ) with a time-dependent clearance" provenance.
- SUBJECT label "The PK model of dopamine D(2)-like receptor ( D2DR ) antagonist sulpiride ( SUL ) as well as that of dexamethasone ( DEX ) with a time-dependent clearance" provenance.
- SUBJECT label "The PK model of dopamine D(2)-like receptor ( D2DR ) antagonist sulpiride ( SUL ) as well as that of dexamethasone ( DEX ) with a time-dependent clearance" provenance.
- SUBJECT label "The PK model of dopamine D(2)-like receptor ( D2DR ) antagonist sulpiride ( SUL ) as well as that of dexamethasone ( DEX ) with a time-dependent clearance" provenance.
- SUBJECT label "The PK model of dopamine D(2)-like receptor ( D2DR ) antagonist sulpiride ( SUL ) as well as that of dexamethasone ( DEX ) with a time-dependent clearance" provenance.
- SUBJECT label "The PK model of dopamine D(2)-like receptor ( D2DR ) antagonist sulpiride ( SUL ) as well as that of dexamethasone ( DEX ) with a time-dependent clearance" provenance.
- SUBJECT label "The PK model of dopamine D(2)-like receptor ( D2DR ) antagonist sulpiride ( SUL ) as well as that of dexamethasone ( DEX ) with a time-dependent clearance" provenance.
- SUBJECT label "The PK model of dopamine D(2)-like receptor ( D2DR ) antagonist sulpiride ( SUL ) as well as that of dexamethasone ( DEX ) with a time-dependent clearance" provenance.
- SUBJECT label "The PK model of dopamine D(2)-like receptor ( D2DR ) antagonist sulpiride ( SUL ) as well as that of dexamethasone ( DEX ) with a time-dependent clearance" provenance.
- SUBJECT label "The PK model of dopamine D(2)-like receptor ( D2DR ) antagonist sulpiride ( SUL ) as well as that of dexamethasone ( DEX ) with a time-dependent clearance" provenance.
- SUBJECT label "The PK model of dopamine D(2)-like receptor ( D2DR ) antagonist sulpiride ( SUL ) as well as that of dexamethasone ( DEX ) with a time-dependent clearance" provenance.